Drugs for Neglected Diseases initiative - DNDi
Pascal Carpentier is currently the Information Systems and Technology Director at Drugs for Neglected Diseases initiative (DNDi). Prior to their current role, Pascal held positions such as Senior Business and Solutions Delivery Manager at NayaMed, Head of Solutions & Delivery at Millennium Foundation, IT Architect at ERI Bancaire, and ICT Officer at GAVI Alliance. Pascal also served as Information Systems Manager at VaccineFund. Pascal holds a PhD in Business-Society Management, an MBA in Business Administration, and a Master's degree in Business Intelligence Specialist.
Drugs for Neglected Diseases initiative - DNDi
2 followers
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.